Resonance Specialities Ltd is engaged in the business of manufacturing of chemicals like pyridine, picoline, cyanopyridine and their derivatives.
- Resonance Specialities Ltd reported Total revenue for Q4 FY23 of ₹18.38 Crore, up from ₹18.27 Crore year on year depicting a growth of 1%.
- Total Expenses for Q4 FY23 of ₹16.58 Crore up, from ₹15.2 Crore year on year, a growth of 9%.
- Consolidated Net Profit of ₹1.24 Crore, down 52% from ₹2.6 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹1.07, down 52% from ₹2.25 in the same quarter of the previous year.